Implementing efficient clinical imaging trials are critical to the development of novel diagnostics and therapeutics. Whether it is identifying availability of existing imaging radiopharmaceuticals, supporting the identification of contract manufacturers or imaging sites or supporting the development of imaging trial protocols, CITRAS has the necessary expertise to support your needs:

• Availability and accessibility of existing tracer supply options

• CDMO and clinical site assessment and selection

• Optimization of study protocols to provide optimal flexibility (adaptive design)

• Study documentation

• Patient Information Sheet / Informed consent